Article Versions Notes

Mitrović JR, Divović-Matović B, Knutson DE, Đoković JB, Kremenović A, Dobričić VD, Randjelović DV, Pantelić I, Cook JM, Savić MM, et al. Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach. Pharmaceutics. 2021; 13(8):1188. https://doi.org/10.3390/pharmaceutics13081188

Mitrović, Jelena R., Branka Divović-Matović, Daniel E. Knutson, Jelena B. Đoković, Aleksandar Kremenović, Vladimir D. Dobričić, Danijela V. Randjelović, Ivana Pantelić, James M. Cook, Miroslav M. Savić, and et al. 2021. "Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach" Pharmaceutics 13, no. 8: 1188. https://doi.org/10.3390/pharmaceutics13081188

Mitrović, J. R., Divović-Matović, B., Knutson, D. E., Đoković, J. B., Kremenović, A., Dobričić, V. D., Randjelović, D. V., Pantelić, I., Cook, J. M., Savić, M. M., & Savić, S. D. (2021). Overcoming the Low Oral Bioavailability of Deuterated Pyrazoloquinolinone Ligand DK-I-60-3 by Nanonization: A Knowledge-Based Approach. Pharmaceutics, 13(8), 1188. https://doi.org/10.3390/pharmaceutics13081188